Skip to Main Content

Paper Details

Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.
J Natl Cancer Inst
149
2017
Breast Cancer, Women, breast cancer, cancers, genetic variants, germline, women
Author NameAffiliation
Lisa MadlenskyHelen Diller Family Comprehensive Cancer Center (LJvV), University of California, Karolinska Institutet
Elad ZivHelen Diller Family Comprehensive Cancer Center (LJvV), University of California, Karolinska Institutet
Elad ZivHelen Diller Family Comprehensive Cancer Center (LJvV), University of California, Karolinska Institutet
Laura J Van't VeerHelen Diller Family Comprehensive Cancer Center (LJvV), University of California, Karolinska Institutet
  • 1 - 4

Datasets